Materia Medica Holding, NPF
Since 1992
Russia
Central Federal District of the Russian Federation
Moscow
129272, st. Trifonovskaya, d. 47, p. 1
Since 1992, Materia Medica Holding has been developing and introducing innovative drugs for the treatment of various diseases.
As of November 2019, more than 20 drugs of various therapeutic areas with a high evidence base are presented in Russia, as well as abroad, including the most famous: Ergoferon, Anaferon, Rengalin, Tenoten, Divaza, Afalaza, Impaza, Subetta and others.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |